Humeds Health Technologies Corp.
Humeds Health Technologies Corp. is a collaborative research and industrialization project company in the field of AI health, officially signed by Suzhou City and Massachusetts Institute of Technology in China. It was founded in 2016 by a team of Chinese international doctoral students who graduated from the MIT Artificial Intelligence Laboratory. The main business of the company is to research, develop and produce portable/wearable devices (hardware) based on mobile Internet and the Internet of Things for remote monitoring of major chronic diseases (cardiovascular and cerebrovascular diseases, cancer, chronic respiratory diseases, diabetes), and automatic/auxiliary diagnostic systems (software) based on health big data processing and artificial intelligence technology that connect all the above hardware devices through mobile phones in the cloud background, so as to provide intelligent big health systems that can be used by non professionals for early detection and daily monitoring of major chronic diseases for thousands of households, community villages and grass-roots units. The company has dozens of related patents, and its products have been certified by domestic and foreign drug regulatory authorities for large-scale production and sales.